UiPath Inc. PATH | NYSE

$13.25 $0.51 | 4.00%

After Hours
$13.3 $0.05 | 0.38%

Company Overview:

Market Cap: $7.28B
PE Ratio: -82.81
52-Week Range: $10.37 - $27.87
Dividend Yield (FWD): 0.00% ($0.00)

3.7 Year Performance Metrics:

Total Return (with DRIP): -80.80% (-35.98% / yr)
Total Return (no DRIP): -80.80% (-35.98% / yr)
Share Price: -80.80%
Dividend Increase: nan%
PATH 3.7-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

PATH Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
PATH Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
PATH Price CAGR:1Y: -46.44%2Y: 2.59%5Y: -28.11%10Y: -15.21%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

PATH Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - PATH
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - PATH
14-Day FREE Trial Get Full Access Now!

PATH Earnings, Revenue, Cash & Debt, Shares Outstaning:

PATH - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
PATH - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
PATH - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
PATH - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
PATH - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
PATH - Cash & Debt
14-Day FREE Trial Get Full Access Now!
PATH - Revenue
14-Day FREE Trial Get Full Access Now!
PATH Revenue CAGR:1Y: 8.82%2Y: 16.18%5Y: N/A10Y: N/A
PATH - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
PATH EPS CAGR:1Y: 459.71%2Y: 100.00%5Y: N/A10Y: N/A
PATH - Net Income
14-Day FREE Trial Get Full Access Now!
PATH Net Income CAGR:1Y: -66.21%2Y: -57.04%5Y: N/A10Y: N/A
PATH - EBITDA
14-Day FREE Trial Get Full Access Now!
PATH EBITDA CAGR:1Y: -22.95%2Y: -18.25%5Y: N/A10Y: N/A
PATH - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
PATH Free Cash Flow CAGR:1Y: -43.66%2Y: 64.64%5Y: N/A10Y: N/A
PATH - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
PATH Free Cash Flow / Share CAGR:1Y: -43.25%2Y: 64.15%5Y: N/A10Y: N/A
PATH - Gross Profit
14-Day FREE Trial Get Full Access Now!
PATH Gross Profit CAGR:1Y: 5.39%2Y: 14.99%5Y: N/A10Y: N/A
PATH - Expenses
14-Day FREE Trial Get Full Access Now!
PATH Expenses CAGR:1Y: 614.81%2Y: -4.24%5Y: N/A10Y: N/A
PATH - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
PATH Shares Outstanding CAGR:1Y: -0.72%2Y: 1.16%5Y: N/A10Y: N/A
PATH - Share Buybacks
14-Day FREE Trial Get Full Access Now!
PATH Share Buybacks CAGR:1Y: 208.93%2Y: 943.75%5Y: N/A10Y: N/A
PATH - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
PATH Stock-Based Comp CAGR:1Y: -8.75%2Y: 3.87%5Y: N/A10Y: N/A
PATH - Dividends
14-Day FREE Trial Get Full Access Now!
PATH Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
PATH - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
PATH Revenue CAGR:1Y: 8.82%2Y: 16.18%5Y: N/A10Y: N/A

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

PATH - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
PATH Actual Revenue CAGR:1Y: 8.82%2Y: 16.18%5Y: N/A10Y: N/A
PATH - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
PATH Actual EPS CAGR:1Y: 459.71%2Y: 100.00%5Y: N/A10Y: N/A
PATH - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
PATH Actual Net Income CAGR:1Y: -66.21%2Y: -57.04%5Y: N/A10Y: N/A
PATH - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
PATH Actual EBITDA CAGR:1Y: -22.95%2Y: -18.25%5Y: N/A10Y: N/A

Ratios, Profit Margins & Return on Capital:

PATH - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
PATH Net Profit Margin CAGR:1Y: -69.01%2Y: -63.05%5Y: N/A10Y: N/A
PATH - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
PATH Gross Profit Margin CAGR:1Y: -3.14%2Y: -1.02%5Y: N/A10Y: N/A
PATH - Price to Earnings
14-Day FREE Trial Get Full Access Now!
PATH - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
PATH - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
PATH - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

PATH Dividends Info:

Annual Dividend: $
Forward Yield: 0%
Ex-Dividend Date:
Lifetime Dividens / Share: $0.00

PATH Dividend History: Dates, Payments & Yield list

Below is a schedule of all PATH dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for PATH

Based on past 3.7-year performance, here are PATH growth metrics:

Share price CAGR of -32.68%
Dividend CAGR of +0%
Using PATH CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

PATH
Current Price$13.25
Start Shares754.72
Start Value$10,000
 
After 10 years:
Final Share Count754.72
Dividends Payment$0.00
Annual Dividends$0
Yield on cost0.00%
Share Price$0.38
Total Dividends$0
Final Value$284

Estimated Future Value + Dividends - PATH

NOTE: Above numbers are our estimate based on PATH's Dividend and Price CAGR over past 3.7 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

UiPath Inc. (PATH) had its IPO on 2021-04-21, and is trader on NYSE stock exchange.

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.

PATH website: https://www.uipath.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial